Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for jak2 protein, human (compound)
Most Correlated Studies
- Bone marrow of B-cell precursor acute lymphoblastic leukemic children with PAX5-related gene fusions
- Lung cancer NCI-H1573, NCI-H1992, NCI-H596 cells treated with Crizotinib, IFN gamma and HGF
- Lung fibroblast IMR-90 cells treated with oncostatin M
- Erythroleukemia cells (TF-1) overexpressing GNB1 K89E 12hr post GM-CSF withdrawal
- CML K-562 cells overexpressing wildtype or mutant CALR and treated with melittin
Most Relevant Literature
- New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation.
- Increased Risk of Thoracic Aortic Aneurysms With JAK2 V617F.
- Rare Causes of Acute Coronary Syndrome: The JAK2 V617F Mutation-Positive Myeloproliferative Neoplasm…
- Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia.
- EnvIRONment modifies polycythemia vera.
Most Relevant Clinical Trials
- An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloprolifer…
- Growth Hormone Signaling in Vivo in Humans
- The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies
- Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal …
- A Study to Evaluate Safety and Efficacy of Panobinostat in Participants With Primary Myelofibrosis
